Mausumee Guha

Person

Carlsbad, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterocyclic compounds and methods of use
- Patent number 10,189,826
- Issue date Jan 29, 2019
- Medivation Technologies LLC
- Brahmam Pujala
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and methods of use
- Patent number 10,183,015
- Issue date Jan 22, 2019
- Medivation Technologies LLC
- Sebastian Bernales
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense oligonucleotides optimized for kidney targeting
- Patent number 8,258,105
- Issue date Sep 4, 2012
- ISIS Pharmaceuticals, Inc.
- Andrew M. Siwkowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and their uses directed to IL-4R alpha
- Patent number 8,153,603
- Issue date Apr 10, 2012
- ISIS Pharmaceuticals, Inc.
- James G. Karras
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense modulation of connective tissue growth factor expression
- Patent number 7,709,630
- Issue date May 4, 2010
- ISIS Pharmaceuticals, Inc.
- William Gaarde
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and their uses directed to IL-4R alpha
- Patent number 7,507,810
- Issue date Mar 24, 2009
- ISIS Pharmaceuticals, Inc.
- James G. Karras
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Heterocyclic Compounds and Methods of Use
- Publication number 20180051013
- Publication date Feb 22, 2018
- Medivation Technologies LLC
- Brahmam Pujala
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic Compounds and Methods of Use
- Publication number 20180028518
- Publication date Feb 1, 2018
- Medivation Technologies, Inc.
- Sebastian Bernales
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND THEIR USES DIRECTED TO IL-4R ALPHA
- Publication number 20120316221
- Publication date Dec 13, 2012
- ISIS Pharmaceuticals, Inc.
- JAMES G. KARRAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE MODULATION OF CONNECTIVE TISSUE GROWTH FACTOR EXPRESSION
- Publication number 20100035964
- Publication date Feb 11, 2010
- ISIS Pharmaceuticals, Inc.
- William Gaarde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND THEIR USES DIRECTED TO IL-4R ALPHA
- Publication number 20090312398
- Publication date Dec 17, 2009
- ISIS Pharmaceuticals, Inc.
- James G. Karras
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BACKBONE MODIFICATIONS TO MODULATE OLIGONUCLEOTIDE TARGETING IN VIVO
- Publication number 20070299028
- Publication date Dec 27, 2007
- Andrew M. Siwkowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND THEIR USES DIRECTED TO IL-4R ALPHA
- Publication number 20070161593
- Publication date Jul 12, 2007
- ISIS Pharmaceuticals, Inc.
- James G. Karras
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antisense oligonucleotides optimized for kidney targeting
- Publication number 20050113326
- Publication date May 26, 2005
- Andrew M. Siwkowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antisense modulation of connective tissue growth factor expression
- Publication number 20050059629
- Publication date Mar 17, 2005
- ISIS Pharmaceuticals, Inc.
- William Gaarde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mausumee Guha

Person

Patents Grantslast 30 patents

Heterocyclic compounds and methods of use

Heterocyclic compounds and methods of use

Antisense oligonucleotides optimized for kidney targeting

Compositions and their uses directed to IL-4R alpha

Antisense modulation of connective tissue growth factor expression

Compositions and their uses directed to IL-4R alpha

Patents Applicationslast 30 patents

Heterocyclic Compounds and Methods of Use

Heterocyclic Compounds and Methods of Use

COMPOSITIONS AND THEIR USES DIRECTED TO IL-4R ALPHA

ANTISENSE MODULATION OF CONNECTIVE TISSUE GROWTH FACTOR EXPRESSION

COMPOSITIONS AND THEIR USES DIRECTED TO IL-4R ALPHA

BACKBONE MODIFICATIONS TO MODULATE OLIGONUCLEOTIDE TARGETING IN VIVO

COMPOSITIONS AND THEIR USES DIRECTED TO IL-4R ALPHA

Antisense oligonucleotides optimized for kidney targeting

Antisense modulation of connective tissue growth factor expression